The focus on p‐tau driven pathogenesis stems from the prominence of p‐tau pathology in CTE, as well as in AD, although precisely which forms of p‐tau are neurotoxic is uncertain (Kimura, Sharma, Ishiguro, & Hisanaga, 2018). This evidence concerns the gene MAPT and Alzheimer disease.